Publications by authors named "Haikuo Ma"

Claim this Profile
D
Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury.
Yuting Ji, Shujing Du, Jingjing Li, Haikuo Ma, Xinhui Wang

Cell Death Discov· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.
Yongjin Hao, Jiawan Ma, Jin Wang, Xiaoliang Yu, Zhanhui Li, Haikuo Ma

Eur J Med Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model.
Yongjin Hao, Jin Wang, Jiawan Ma, Xiaoliang Yu, Zhanhui Li, Haikuo Ma

Bioorg Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.
Xiaoliang Yu, Haikuo Ma, Bohan Li, Yuting Ji, Yayun Du, Feng Ma

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.
Yongjin Hao, Chengkui Yang, Chang Shu, Zhanhui Li, Kaijiang Xia, Haikuo Ma

Bioorg Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold.
Shuwei Wu, Qing Yang, Yuting Ji, Sheng Tian, Haikuo Ma

Future Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.
Zhanhui Li, Yongjin Hao, Chengkui Yang, Qing Yang, Shuwei Wu, Haikuo Ma

Eur J Med Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ring closure strategy leads to potent RIPK3 inhibitors.
Shuwei Wu, Chen Xu, Kaijiang Xia, Yu Lin, Sheng Tian, Haikuo Ma

Eur J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.
Kaijiang Xia, Fang Zhu, Chengkui Yang, Shuwei Wu, Yu Lin, Haikuo Ma

Front Cell Dev Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of pyrrolidine based CXCR4 antagonists with in vivo anti-tumor metastatic activity.
Zhanhui Li, Xu Wang, Yu Lin, Yujie Wang, Shuwei Wu, Haikuo Ma

Eur J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative desulfurization of model oil over Ta-Beta zeolite synthesized via structural reconstruction.
Zhiguo Zhu, Haikuo Ma, Hao Xu, Bo Wang, Peng Wu

J Hazard Mater· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines.
Yu Lin, Zhanhui Li, Haikuo Ma, Yujie Wang, Xu Wang

ChemMedChem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.
Yu Lin, Zhanhui Li, Chen Xu, Kaijiang Xia, Shuwei Wu, Haikuo Ma

Bioorg Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrothermal synthesis of boron-free Zr-MWW and Sn-MWW zeolites as robust Lewis acid catalysts.
Zhiguo Zhu, Yejun Guan, Haikuo Ma, Hao Xu, Jin-Gang Jiang

Chem Commun (Camb)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural optimization of aminopyrimidine-based CXCR4 antagonists.
Fang Zhu, Yujie Wang, Qian Du, Wenxiang Ge, Zhanhui Li, Haikuo Ma

Eur J Med Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural optimization on a virtual screening hit of smoothened receptor.
Shiwei Song, Jinyi Jiang, Li Zhao, Qin Wang, Wenfeng Lu, Haikuo Ma

Eur J Med Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Jue Hou, Jie Ju, Zili Zhang, Cong Zhao, Zhanhui Li, Haikuo Ma

Cell Death Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel hedgehog inhibitor for the treatment of hematological malignancies.
Peng Lin, Yuanming He, Guodong Chen, Haikuo Ma, Jiyue Zheng, Xinliang Mao

Anticancer Drugs· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.
Wenfeng Lu, Dihua Zhang, Haikuo Ma, Sheng Tian, Jiyue Zheng

Eur J Med Chem· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
Qin Chen, Haoran Zhang, Meng Wu, Qin Wang, Lusong Luo, Haikuo Ma

J Pharmacol Sci· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.
Zhanhui Li, Yujie Wang, Chunyan Fu, Xu Wang, Jun Jun Wang, Haikuo Ma

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
Haikuo Ma, Qin Chen, Fang Zhu, Jiyue Zheng, Jiajun Li

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity.
Wenfeng Lu, Yongqiang Liu, Haikuo Ma, Jiyue Zheng, Sheng Tian

ACS Chem Neurosci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a New Series of Potent Adenosine A Receptor Antagonists Based on 4-Amino-5-carbonitrile Pyrimidine Template for the Treatment of Parkinson's Disease.
Zhaohui Yang, Linlang Li, Jiyue Zheng, Haikuo Ma, Sheng Tian

ACS Chem Neurosci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold.
Zhixiang Xu, Xiangxiang Xu, Ruadhan O'Laoi, Haikuo Ma, Jiyue Zheng

Bioorg Med Chem· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis